Cosmo Pharmaceuticals N.V. logo

Cosmo Pharmaceuticals N.V. (0RGI)

Market Closed
19 Jun, 15:30
LSE LSE
68. 20
CHF
+0.35
+0.5158%
CHF
- Market Cap
104.48 P/E Ratio
8% Div Yield
5,018 Volume
0 Eps
67.85 CHF
Previous Close
Add Transaction
Day Range
66.6 69.45
Year Range
53.6 129.6
Want to track 0RGI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Cosmo Pharmaceuticals N.V. logo
0RGI Cosmo Pharmaceuticals N.V.
5 Mar 2026
-
-
Cosmo Pharmaceuticals N.V. logo
0RGI Cosmo Pharmaceuticals N.V.
23 Jul 2025
-
-
Cosmo Pharmaceuticals N.V. logo
0RGI Cosmo Pharmaceuticals N.V.
23 May 2025
-
-
Cosmo Pharmaceuticals N.V. logo
0RGI Cosmo Pharmaceuticals N.V.
24 Jul 2024
-
-
Cosmo Pharmaceuticals N.V. logo
0RGI Cosmo Pharmaceuticals N.V.
24 May 2024
-
-

0RGI Earnings Reports FAQ

What is the earnings per share (EPS) for 0RGI?

The current EPS is 0.

What is the company's earnings growth rate?

Cosmo Pharmaceuticals N.V has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Cosmo Pharmaceuticals N.V has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Cosmo Pharmaceuticals N.V are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 0RGI at this time, as Cosmo Pharmaceuticals N.V has no recent EPS data to calculate it.